AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer
Anna C. Beck, Edward Cho, Jeffrey R. White, Lily Paemka, Tiandao Li, Vivian W. Gu, Dakota T. Thompson, Kelsey E. Koch, Christopher Franke, Matthew Gosse, Vincent T. Wu, Shannon R. Landers, Anthony J. Pamatmat, Mikhail V. Kulak, Ronald J. Weigel
Molecular Cancer Research Mar 2021, DOI: 10.1158/1541-7786.MCR-20-0867